MGIM
MGNX icon

M&G Investment Management’s MacroGenics MGNX Stock Holding History

M&G Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,838
Closed -$333 – 644
2021
Q3 		$333 Sell
15,838
-11,005
-41% -$265K ﹤0.01% 697
2021
Q2 		$725 Buy
+26,843
New +$786K ﹤0.01% 651

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

M&G Investment Management's MGNX Position: Q4 2021 in Review

M&G Investment Management sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 15,838 shares — an estimated $333 sold.

M&G Investment Management first reported a position in MGNX in Q2 2021 and held it in 2 quarters. The position peaked at $725 in Q2 2021. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

  • M&G Investment Management reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 15,838 MacroGenics shares in Q4 2021, an estimated $333.
  • M&G Investment Management first reported a position in MacroGenics in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's MacroGenics position peaked at $725 in Q2 2021.
  • 156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.